Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88064499 |
LAW OFFICE ASSIGNED |
LAW OFFICE 104 |
MARK SECTION |
MARK |
Design only |
STANDARD CHARACTERS |
NO |
USPTO-GENERATED IMAGE |
NO |
OWNER SECTION |
NAME |
Actelion Pharmaceuticals Ltd. |
STREET |
Gewerbestrasse 16 |
CITY |
Allschwil |
ZIP/POSTAL CODE |
CH-4123 |
COUNTRY |
Switzerland |
PHONE |
732-524-2889 |
FAX |
732 524 6341 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Human pharmaceuticals for treatment of pulmonary arterial hypertension |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
02/26/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/clfjnj/ |
SIGNATORY'S NAME |
Cheryl Foytlin |
SIGNATORY'S POSITION |
Attorney of Record, NY Bar |
DATE SIGNED |
06/26/2019 |
FILING INFORMATION |
SUBMIT DATE |
Wed Jun 26 09:09:25 EDT 2019 |
TEAS STAMP |
USPTO/ESU-XXX.XX.XXX.XX-2
0190626090925508775-88064
499-620cb3b6d99b670c97a30
cd833653948a604c218989b9b
838cfd07150156d7fa1e2-DA-
13410-2019062608221239707
8 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: Design only
SERIAL NUMBER: 88064499
The applicant, Actelion Pharmaceuticals Ltd., having an address of
Gewerbestrasse 16
Allschwil, CH-4123
Switzerland
732-524-2889
732 524 6341
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 02/26/2019.
For International Class 005:
Current identification: Human pharmaceuticals for treatment of pulmonary arterial hypertension
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /clfjnj/ Date Signed: 06/26/2019
Signatory's Name: Cheryl Foytlin
Signatory's Position: Attorney of Record, NY Bar
RAM Sale Number: 88064499
RAM Accounting Date: 06/26/2019
Serial Number: 88064499
Internet Transmission Date: Wed Jun 26 09:09:25 EDT 2019
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.XX-2019062609092550
8775-88064499-620cb3b6d99b670c97a30cd833
653948a604c218989b9b838cfd07150156d7fa1e
2-DA-13410-20190626082212397078